ALLIANCEBERNSTEIN L.P. - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 94 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2022$50,000
-59.0%
21,600
-15.6%
0.00%
Q4 2021$122,000
-40.2%
25,6000.0%0.00%
Q3 2021$204,000
+14.6%
25,6000.0%0.00%
Q2 2021$178,000
-3.8%
25,600
+9.4%
0.00%
Q1 2021$185,000
-1.6%
23,400
-2.1%
0.00%
Q4 2020$188,000
-1.1%
23,900
-10.8%
0.00%
Q3 2020$190,000
-17.0%
26,800
+8.1%
0.00%
Q2 2020$229,000
+387.2%
24,800
+148.0%
0.00%
Q1 2020$47,00010,0000.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Yu Fan 112,044$258,0003.49%
Aisling Capital Management LP 1,691,151$3,890,0002.10%
Sio Capital Management, LLC 871,101$2,004,0000.66%
Bain Capital Life Sciences Investors, LLC 2,847,689$6,550,0000.64%
Samsara BioCapital, LLC 883,720$2,033,0000.51%
Ghost Tree Capital, LLC 686,599$1,579,0000.34%
Nantahala Capital Management 3,200,593$7,361,0000.33%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 245,678$565,0000.29%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,059,894$9,338,0000.28%
Lion Point Capital, LP 300,000$690,0000.16%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders